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1684-1182/Copyright ª 2015, TaiwanAbstract Background/Purpose: French Polynesia is an overseas territory located in the South
Pacific. The incidence of tuberculosis in French Polynesia has been stable since 2000 with an
average of 20 cases/y/100,000 inhabitants. Molecular epidemiology of Mycobacterium tuber-
culosis in French Polynesia is unknown because M. tuberculosis isolates have not been
routinely genotyped.
Methods: From 2009 to 2012, 34 isolates collected from 32 French Polynesian patients were
identified as M. tuberculosis by probe hybridization. These isolates were genotyped using spo-
ligotyping and 24-loci mycobacterial interspersed repetitive units (MIRUs)-variable number of
tandem repeat (VNTR). Spoligotype patterns obtained using commercial kits were compared
with the online international database SITVIT. MIRU-VNTR genotyping was performed using
an in-house protocol based on capillary electrophoresis sizing for 24-loci MIRU-VNTR genotyp-
ing.
Results: The results of the spoligotyping method revealed that 25 isolates grouped into six pre-
viously described spoligotypes [H1, H3, U likely (S), T1, Manu, and Beijing] and nine isolates
grouped into six new spoligotypes. Comparison with the international database MIRU-
VNTRplus distributed 30 isolates into five lineages (Haarlem, Latin American Mediterranean,
S, X, and Beijing) and four as unassigned isolates.
Conclusion: Genotyping identified four phylogenetic lineages belonging to the modern Euro
eAmerican subgroup, one Beijing genotype responsible for worldwide pandemics, includingerche et de veille sur les maladies infectieuses e´mergente, Institut Louis Malarde´, PO Box 30, 98713
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tuberculosis.
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Mycobacterium tuberculosis complex infections are one of
the major global public health problems, especially in the
Pacific region. The Pacific is a very large area and the sit-
uation of tuberculosis (TB) differs from one region to
another. The situation is alarming in the Western Pacific
region (21% of the global TB burden), where recent esti-
mates indicate that there are approximately 1.9 million
incident TB cases and 260,000 deaths annually, with the
situation exacerbated by TBehuman immunodeficiency
virus (HIV) co-infection and the emergence and spread of
multidrug-resistant TB.1 Regarding TB surveillance, the
Pacific TB Laboratory Initiative was created in 2004 in
collaboration with the Western Pacific Regional Office of
the World Health Organization (WHO), the Secretariat of
the Pacific Community, the U.S. Centers for Diseases Con-
trol and Prevention, and reference laboratories located in
Australia and New Zealand, with the main objective of
improving the quality of sputum microscopy and surveil-
lance for TB drug resistance.2 In the Western Pacific region,
the prevalence of TB decreased by 46% and the mortality by
42% from 2000 to 2008.2 The epidemiology of TB is different
in the Pacific Island Countries and Territories (PICTs)
compared with the Western Pacific region (South East Asia).
The PICTs comprise 22 countries and territories and three
subregions, namely, Micronesia, Melanesia, and Polynesia.
From 2000 to 2008, the notification rate of TB cases in the
PICTs ranged from 159 to 207 cases/100,000 inhabitants in
Melanesia, from 91 to 147 cases/100,000 inhabitants in
Micronesia, and from 15 to 22 cases/100,000 inhabitants in
Polynesia; the highest TB case notification rate was re-
ported in Kiribati (Micronesia), 399 cases/100.000 in-
habitants in 2006.3 Six PICTs were identified as high-burden
TB countries (TB cases  70/100,000 inhabitants).3 In the
PICTs, only 45 multidrug-resistant M. tuberculosis isolates
were reported between 2004 and 2009, with the highest
prevalence being reported among migrant workers in
Micronesia.3 Although rates of drug resistance and
multidrug-resistant M. tuberculosis were low in the PICTs
up to 2009 (except in the Federated States of Micronesia),
formal drug-resistance surveillance has not been widely
implemented in the region.
French Polynesia is an overseas French territory located
in the South East Pacific (274,000 inhabitants; 118 islands
distributed in 5 archipelagos, 67 islands are inhabited). In
French Polynesia, the TB control program is coordinated by
the Director of Health/Ministry of Health. Based on
mandatory clinical declarations, the TB incidence has been
stable since 2000 with an average of 20 cases/100,000 in-
habitants,3,4 and 80% of the cases being pulmonary TB.
From 2000 to 2012, no case of TB multidrug resistance andsman DA, et al., Diversity of Myc
ion (2015), http://dx.doi.org/10.no M. tuberculosiseHIV co-infections were reported in
French Polynesia.4
Concerning the genetic diversity of M. tuberculosis in
the Pacific region, data are principally available for the
Western Pacific region.5,6 Because there are no laboratory
tools, very little is known about the molecular epidemi-
ology of M. tuberculosis in the PICTs, except for studies
conducted in Kiribati (Micronesia)7 and Papua New Guinea
(Melanesia).8
Molecular tools have been proven to be useful in
obtaining a better understanding of TB epidemiology.9 An
initial study on M. tuberculosismolecular epidemiology was
conducted in French Polynesia in 1991/1992 using the
IS6110 restriction fragment length polymorphism,10 how-
ever, M. tuberculosis isolates have not been routinely
genotyped using new molecular tools.
To describe the genetic diversity among clinical isolates
of M. tuberculosis in French Polynesia, we genotyped 34 M.
tuberculosis complex strains isolated over a 4-year period
using spoligotyping and 24-loci mycobacterial interspersed
repetitive units (MIRUs)-variable number of tandem repeat
(VNTR).
Methods
Ethics statement
This study was approved by the Ethics Committee of French
Polynesia under reference Number 61/CEPF. The study was
a noninterventional study conducted on samples collected
for TB laboratory diagnosis and under medical prescription
by a physician.
Sample collection
The study was conducted on M. tuberculosis strains isolated
from 2009 to 2012 at the Institut Louis Malarde´, Tahiti, a
French Polynesian health and research institute in charge of
infectious diseases control and surveillance, which receives
samples from the whole of French Polynesia. Specimens
were received with a confidential medical questionnaire
form.
Clinical isolate processing and drug-susceptibility
testing
Specimen processing for TB diagnosis was performed at the
Institut Louis Malarde´, Tahiti. All specimens received for
tuberculosis diagnosis were routinely investigated using
direct microscopic examination after ZiehleNeelsen stain-
ing and cultured on egg-based LowensteineJensen mediumobacterium tuberculosis lineages in French Polynesia, Journal of
1016/j.jmii.2015.05.018
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identification of colonies was made using ZiehleNeelsen
staining before hybridization with M. tuberculosis complex
probes (AccuProbe M. tuberculosis complex, bioMe´rieux, La
Balme-les-Grottes, France). For all strains identified as M.
tuberculosis, antibiotic susceptibility was performed using
a broth microdilution method for rifampin, isoniazid,
streptomycin, and ethambutol.
Genotyping methods
Genotyping was performed at the Reference Laboratory for
Mycobacteria of the Institut Hospitalo-Universitaire Me´di-
terrane´e Infection, Marseille, France. Genotyping was
performed using Beijing typing by polymerase chain reac-
tion (PCR), spoligotyping, and 24-loci MIRUs-VNTR.
Beijing typing
To screen Beijing isolates, real-time PCR was performed
with primers targeting an IS6110 insertion in Rv2820 that isFigure 1. Geographic distribution of the 34 Mycobacterium tuber
Each lineage is represented by a different color. LAM Z Latin Ame
Please cite this article in press as: Osman DA, et al., Diversity of Myc
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.unique to the Beijing lineage.11 The real-time PCR mix
consisted of 10 mL of MasterMix (Eurogentec, Angers,
France), forward (50-CTCGGCAGCTTCCTCGAT-30) and
reverse (50-CGAACTCGAGGCTGCCTACTAC-30) primers
(0.5 mL each of 20 pM working stocks), 0.5 mL of 0.1 nmol/mL
working stock of the probe (6VIC-AACGCCAGA-
GACCAGCCGCCGGCT), 3.5 mL nuclease-free water, and 5 mL
DNA. The reactions were set up in a 96-well PCR plate and
processed on a CFX96 real-time PCR system (Bio-Rad,
Marnes-la-Coquette, France). PCR cycling parameters were
as follows: 50C for 2 minutes followed by 40 cycles of 95C
for 5 minutes, 95C for 1 second, and 60C for 35 seconds
and 45C for 30 seconds.Spoligotyping
Spoligotype patterns,12 obtained using a commercial kit
according to manufacturer guidelines (Gentaur, Paris,
France), were compared using the online international M.
tuberculosis molecular markers spoligotype databaseculosis isolates in French Polynesia with a focus on Tahiti Island.
rican Mediterranean.
obacterium tuberculosis lineages in French Polynesia, Journal of
1016/j.jmii.2015.05.018
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ONLINE/).13e15MIRU-VNTR genotyping
We developed an in-house protocol based on capillary
electrophoresis sizing for performing MIRU-VNTR genotyp-
ing. Prior to the amplification, the concentration of DNA
extracts was determined using the NanoDrop ND-1000
spectrophotometer (Thermo Scientific, Wilmington, DE,
USA). DNA was then diluted to a final concentration of 1 ng/
mL and stored at 20C. PCRs for the MIRU-VNTR manual
typing were conducted using HotStartTaq polymerase kit
(QIAGEN, Marnes-la-Coquette, France) including the Q so-
lution (20 mL) containing 2 mL of the DNA at 1 ng/mL and
18 mL of premix for the 24 loci as described by Supply.16 In
this study, to determine the amplicon fragment sizes, we
used the LabChip GXII system (PerkinElmer, Hopkinton, MA,
USA) consisting of an array of 12 short capillaries covering
the size range from 50 bp to 5 kb and prefilled with gel
polymers. The samples were analyzed in a 96-well plate in a
single experiment without intervention. Because the sipper
is rinsed between samples, cross-contamination was avoi-
ded. PCR products were diluted 10-fold to make up a finalTable 1 Clinical description of 32 patients and the 34 Mycobac
Groupsa All Haarlem L
Patients characteristicsb
Age (y)
<20 20 22 0
20e60 65 67 1
>60 15 11 0
Sexa
Female 20 56 0
Male 80 44 1
Clinical presentationb
Cough 74 78 1
Asthenia 59 56 1
Weight loss 50 44 1
Hemoptysis 21 11 0
Fever 50 33 1
Sweats 21 33 1
Home living conditions
Number of persons at home 5.5 5 1
Number of rooms at home 3.5 4 N
Positive AFBb 41 22 1
Organ involvementb
Pulmonary involvement 65 89 1
Extrapulmonary involvement 32 33 0
Outcomeb
Treatment completed 91 100 1
Lost to follow up 6 0 0
Death 3 0 0
a Based on MIRU-VNTR.
b Results expressed in percentages.
AFBZ acid fast bacilli; LAMZ Latin American Mediterranean; MIRUZ
VNTR Z variable number of tandem repeat.
Please cite this article in press as: Osman DA, et al., Diversity of Myc
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.volume of 20 mL with distilled water and analyzed using the
HT DNA high sensitivity LabChip Kit (PerkinElmer). The
assay was carried out according to the manufacturer’s in-
structions. PCR products were loaded in a systematic
manner in which the M. tuberculosis H37Rv reference strain
was added as a control for size assignments. The resulting
gel images were stored as a .tiff file. Size for each band was
determined using both a ladder and internal markers. Copy
numbers were obtained by comparing these band sizes with
an allele naming table for each tandem repeat locus made
available elsewhere and were saved in Microsoft Excel
(Microsoft, Redmond, WA, USA) format. To distribute the
MIRU-VNTR patterns into lineages, tools available on the
MIRU-VNTRplus website (http://www.miru-vntrplus.org)
were applied.Clustering analysis
The Hunter and Gaston Discriminatory Index (HGDI) was
used to calculate the discriminatory power of both
methods.17 HGDI is calculated using the following
formula: 1
"
1
NðN1Þ
Ps
JZ1 njðnj 1Þ
#
.terium tuberculosis isolates in French Polynesia, 2009e2012
AM S Beijing X group Unassigned
45.5 0 0 0
00 45.5 100 87 100
9 0 13 0
9 0 0 50
00 91 100 100 50
00 54 NA 87 100
00 64 NA 38 100
00 27 NA 75 75
18 NA 38 25
00 45.5 NA 63 75
00 9 NA 13 25
6.6 15 4 6.3
A 3.2 1 3 4
00 9 100 38 100
00 100 100 87 100
55 0 13 25
00 73 100 100 100
18 0 0 0
9 0 0 0
mycobacterial interspersed repetitive unit; NAZ Not available;
obacterium tuberculosis lineages in French Polynesia, Journal of
1016/j.jmii.2015.05.018
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Sample stains, patient characteristics, and drug-
susceptibility testing
From 2009 to 2012, 34 M. tuberculosis complex clinical
isolates (MT1eMT34) collected from 32 French Polynesian
patients were genotyped. M. tuberculosis strains were
isolated from respiratory tract specimens, pleural effusion
samples, and biopsy specimens (lung scan-guided and
lymph node biopsies). Patients lived in 19 different cities on
five different islands of three French Polynesian archipel-
agos; the location of the 34 strains isolated from the 32
patients is reported in Figure 1. Patient demographic
characteristics and available clinical data for all the pa-
tients are reported in Table 1. All patients were new
confirmed cases of tuberculosis according to the WHO
classification for TB cases,18 with the exception of one
patient with positive M. tuberculosis isolates (MT33 and
MT34) cultured in 2011, who was previously treated in 2009
for pulmonary tuberculosis and was considered lost to
follow up. The MT33 and MT34 isolates obtained from this
patient displayed the same genotype suggesting a relapse.
Two young patients (sputum isolates MT11 and MT15) were
investigated as contacts of a nearby confirmed case of
pulmonary tuberculosis whereas all other individuals were
suspected of tuberculosis prior to specimen collection on
the basis of clinical and/or radiological signs. A 75-year-old
man suffering from lymphoma and treated with chemo-
therapy died during treatment. For one patient, the MT24
isolate from a cervical lymph node and the MT29 isolateFigure 2. Neighbor-joining (NJ) tree combining of (A) 24-loci MIR
strains investigated in French Polynesia. Six lineages were identi
MIRU Z mycobacterial interspersed repetitive unit; VNTR Z varia
Please cite this article in press as: Osman DA, et al., Diversity of Myc
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.from sputum yielded the same spoligotype and clustered in
the same MIRU-VNTR group identified. All strains were
susceptible to the four tested antibiotics except the isolate
MT31, isolated from a patient from the Marquesas archi-
pelago, which was resistant to streptomycin.
All patients were treated with a first-line antibiotic
regimen for tuberculosis (2 rifampin, isoniazid, pyr-
azinamide, and ethambutol þ 4RH (rifampicin þ isoniazid)
regimen) as recommended by the WHO18 and French In-
fectious Diseases Society. None of the patients was co-
infected with HIV.
Beijing typing
First-line screening of the isolates by real-time PCR Beijing
lineage yielded only one positive isolate (MT22).
Spoligotyping
The 24 isolates were scattered into 12 spoligotypes.
Twenty-five strains were scattered into six previously
described spoligotypes: H1 (6 strains), H3 (3 strains), U
likely S (6 strains), T1 (8 strains), Manu2 (1 strain), and one
Beijing strain isolated from an incarcerated patient (MT22).
SIT62 (H1 variant), SIT50, and SIT75 (H3 variants) were the
dominant clusters. Nine strains exhibited patterns not
previously reported in the list of all spoligotype interna-
tional types, consisting of three isolatesdMT8, MT15, and
MT21 (spoligotype “A”)dtwo isolatesdMT5 and MT17
(spoligotype “B”)dand one isolate eachdMT9, MT23,
MT26, and MT27 (spoligotypes “CeF”).U-VNTR and (B) spoligotyping of 34 Mycobacterium tuberculosis
fied and are represented by the same colors as in Figure 1.
ble number of tandem repeat.
obacterium tuberculosis lineages in French Polynesia, Journal of
1016/j.jmii.2015.05.018
6 D.A. Osman et al.
+ MODELMIRU-VNTR
The MIRU-VNTR loci of the 34 isolates are reported in
Figures 2 and 3.19 Twenty-nine isolates (85.3%) belonged to
the modern EuroeAmerican lineage: 11 isolates were
identified as members of the S lineage, one of the Latin
American Mediterranean (LAM) lineage, nine isolates of the
Haarlem lineage, and eight of the X lineage.
The similarity option of the MIRU-VNTRplus website
(http://www.miru-vntrplus.org) confirmed isolate MT22 as
a Beijing group B (East Asian lineage).7
Tree-based analysis was adopted to enable the assign-
ment of the other isolates to lineages.19 Eleven isolates
were identified as members of the S lineage, one of the LAM
lineage, nine of the Haarlem lineage, and eight of the X
lineage. Four isolates exhibited a unique profile different
from the ones available in the database (February 2015).
Combined spoligotyping and MIRU-VNTR
Overall, 15/34 (44%) isolates genotyped were identified to
be similar using MIRU-VNTR and spoligotyping with a 0.84
HGDI.17
Discussion
A previous study of 64 M. tuberculosis isolates collected in
1991/1992 in French Polynesia found 38 different IS6110Figure 3. Minimum spanning tree calculated using MIRU-VNTRpl
five. Circles and color indicate, respectively, strain number and clus
between circles indicates distance between two strains. Circle (a) i
and (c) contain, respectively, two strains: MT3, MT30 and MT4
VNTR Z variable number of tandem repeat.
Please cite this article in press as: Osman DA, et al., Diversity of Myc
Microbiology, Immunology and Infection (2015), http://dx.doi.org/10.restriction fragment length polymorphism patterns, with
83% of isolates grouped into 11 clusters.10 These data sug-
gested that, in addition to reactivation of latent tubercu-
losis, active TB circulation was still ongoing in French
Polynesia. Twenty years later, this study indicates that the
EuroeAmerican lineage predominates in French Polynesia.
We detected only one Beijing isolate in French Polynesia,
whereas this lineage comprised 49% of isolates in Kiribati
(Micronesia)7 and 21.9% in Papua New Guinea (Melanesia).8
The Beijing lineage is also largely represented in the
Western Pacific (South East Asia), with 30% of the isolates in
Cambodia5 and 32.5% in Vietnam.6 Nevertheless, the
detection of one Beijing isolate in French Polynesia is in
agreement with the global dissemination of the Beijing
lineage of M. tuberculosis,20 suggesting a need for
increased awareness to limit its spread within the pop-
ulations. One isolate was identified as belonging to the
Manu lineage. The Manu lineage belongs to the Indo-
Oceanic family and, along with the East AfricaneIndian
family, they are two ancestral families of the principal
genetic group 1 characterized by an intact disseminated
TbD1 locus.21,22 In Egypt, the high proportion of this
ancestral lineage led the authors to suggest that the Manu
lineage could be the missing link between modern and
ancestral lineages of M. tuberculosis.23
In the PICTs, molecular epidemiological data about M.
tuberculosis are available for Kiribati (Micronesia subre-
gion),7 Papua New Guinea (Melanesia subregion),8 and
French Polynesia (Polynesia subregion, from this study). Inus and a maximum locus difference within a clonal complex of
ter, using the same color code as in Figures 1 and 2. The number
s constituted of three strains (MT2, MT16, and MT33); circles (b)
, MT19. MIRU Z mycobacterial interspersed repetitive unit;
obacterium tuberculosis lineages in French Polynesia, Journal of
1016/j.jmii.2015.05.018
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with 49% of the isolates in Kiribati,7 76.9% in Papua New
Guinea,8 and 85.3% in French Polynesia. The Euro-
eAmerican lineage also predominates in New Zealand
(37.8% of the isolates). In New Zealand-born individuals,
Maori and New ZealandeEuropean share the same pre-
dominant lineages.24
In the PICTs, different percentages of the predominant
lineage combined with the distribution of other lineages are
in accordance with the high diversity among Pacific Islands
in terms of population (Polynesian, Melanesian,
Micronesia), country size, medical care capacities, socio-
economical conditions, lack of global exchanges (French-
and English-spoken countries, >1200 languages), and the
large geographic area (22 Pacific Island Countries and Ter-
ritories; approximately 25,000 islands and islets). The dif-
ference in the prevalence is principally recorded for the
Beijing isolate, which represented 49% of the strains in
Kiribati,7 2.9% in French Polynesia, and 21.9% in Papua New
Guinea.8
Epidemiology is different in the Western Pacific (South
East Asian) region in which the predominant lineage is the
East AfricaneIndian lineage with 59% of the strains in
Cambodia5 and 50.7% in Vietnam (East Afri-
caneIndianeVietnam genotype).6 The East AfricaneIndian
lineage also predominates in Australia (28.5% of the
isolates).25
Overall, these results suggest that two M. tuberculosis
lineages predominate in the Pacific area, with the Euro-
eAmerican lineage being the predominant lineage in the
PICTs (Melanesia, Micronesia, and Polynesia subregions) and
in New Zealand. The East AfricaneIndian lineage is the
predominant lineage in the Western Pacific and in Australia.
The low incidence of TB in French Polynesia, combined
with the divergence in circulating strains, is consistent with
epidemiological patterns encountered in developed coun-
tries. Modern and ancestral strains of M. tuberculosis are in
circulation in French Polynesia. This study also allowed the
detection of new spoligotypes that will be further
characterized.Conflicts of interest
All contributing authors declare no conflicts of interest.References
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